Navigation Links
Pharmasset Reports Fiscal Year End 2008 Financial Results
Date:12/11/2008

by Bukwang Pharmaceuticals in South Korea under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, has completed a 4-week clinical trial in combination with Pegasys(R) plus Copegus(R) through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial. Pharmasset also anticipates filing an IND for its second generation nucleotide inhibitor for HCV, PSI-7851 in the first quarter of 2009. Pegasys(R) and Copegus(R) are registered trademarks of Roche.

    Contact
    Richard E. T. Smith, Ph.D.
    VP, Investor Relations and Corporate Communications
    richard.smith@pharmasset.com
    Office: +1 (609) 613-4181

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation, the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2008 fi
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
2. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
3. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
4. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
5. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
6. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
7. Pharmasset Receives Notice of Allowance
8. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  Caradigm today ... a solution designed to help healthcare organizations ... data while supporting their compliance with data ... represents a milestone in the delivery of ... capabilities for health systems. ...
(Date:6/19/2013)... , June 19, 2013 ... recently added DrugPatentWatch to its extensive ... )      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) ... information on pharmaceutical, drug patents and ... the critical business functions of patent ...
(Date:6/19/2013)... 2013 DST Health Solutions, LLC (DSTHS), a ... plans, integrated delivery systems, and health care providers, has ... Service (MDMS) has jumped significantly. A ... pricing of medical prescription drug claims, MDMS ... medical drug claims processes. As specialty drug demand grows ...
Breaking Medicine Technology:Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3
(Date:6/19/2013)... DiscountFurnaceFilter.com, the number one solution for homeowner’s ... Compressor Saver kit at an exceptional price. The 5-2-1 Compressor ... air conditioning unit during start up, saving wear and tear ... unit burn out. , The 5-2-1 Compressor Saver ... uses less power to start and drastically reduces the rush ...
(Date:6/19/2013)... Boca Raton, FL (PRWEB) June 19, 2013 ... spoke about the positive changes and growth that has occurred ... his nationwide travel club. , Shuman said, "Travel Services has ... program to heights beyond belief. Membership is up, even ... agents to meet the demands of members." , Having been ...
(Date:6/19/2013)... published today in Menopause International , suggests ... sex, and less satisfying sex compared to their ... considerably less likely to access appropriate treatment for ... The first-of-its-kind study, called the CLarifying vaginal atrophy,s ... that British post-menopausal women with vaginal atrophy are ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The former ... Cardinals, James Loomis, MD, now serves as director of ... MO. It was his own personal encounter with a ... documentary, Forks Over Knives , that he credits ... own health and his medical practice. , “The average ...
(Date:6/19/2013)... HI (PRWEB) June 19, 2013 ... company is dedicated to being an effective and cost ... reception needs. They have partnered up with Tom Barefoot’s ... and discounts on most of Hawaii’s activities. , They ... how clients can get the lowest prices on their ...
Breaking Medicine News(10 mins):Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 3Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2
... QMed, Inc. (Nasdaq,Symbol: QMED) today announced financial results for ... three-month period decreased to,$751,788 from $1,728,676 in the prior ... $(0.06) per share on a diluted basis, compared to,net ... diluted basis, for the,same period a year ago., ...
... Fla., April 18 Breckenridge Pharmaceutical,Inc. announced today ... granted,final approval for the Company,s Abbreviated New Drug ... Nordisk,s Activella Tablets,(Estradiol/Norethindrone Acetate 1.0mg / 0.5mg) Tablets., ... Activella(R), a,brand product marketed by Novo Nordisk(R), which ...
... up efforts to vaccinate young women against virus that causes ... For the first time, a doctor,s arsenal now includes a ... targets human papillomavirus, or HPV, which causes virtually all cases ... American women. , And health-care providers are beginning to integrate ...
... April 18 The following is being,issued by ... Coalition of Full Service Community Hospitals:, Congress ... the,conflict of interest it creates between a patient,s ... over the last year, the House of,Representatives has ...
... weight gain is an early symptom, not a direct cause ... obesity it causes, is the actual cause of metabolic syndrome, ... of Texas Southwestern Medical Center at Dallas. , Metabolic ... risk of developing insulin resistance, fatty liver, heart disease and ...
... Calif., April 18 Accenx Technologies, Inc., a,leading ... care data integration solutions, announces today R. Scott ... & Marketing., Mr. Harper is a results-driven ... in establishing strong sales organizations,working in unison with ...
Cached Medicine News:Health News:QMed, Inc. Reports First Quarter Results 2Health News:QMed, Inc. Reports First Quarter Results 3Health News:QMed, Inc. Reports First Quarter Results 4Health News:QMed, Inc. Reports First Quarter Results 5Health News:Dealing Cervical Cancer a Knockout Blow 2Health News:Dealing Cervical Cancer a Knockout Blow 3Health News:Statement: Congress Should Include the Physician Self-Referral Provision in the Farm Bill for Patients and Communities 2Health News:Metabolic Syndrome Triggered by Overeating, Not Obesity 2Health News:Accenx Technologies Announces New Leadership in Sales and Marketing Division 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: